• Home
  • Case Studies
  • Cutting dermatology wait lists from 80 weeks to 48 hours in Frimley ICB

Cutting dermatology wait lists from 80 weeks to 48 hours in Frimley ICB

Published 17 April, 2024

Xyla partnered with Frimley ICB to deliver a consultant led teledermatology service designed to reduce long dermatology waits, improve the patient experience and support clinicians with faster access to expert review.

Key stats

40% reduction

in 2 week wait referrals sent to secondary care

40%

of overall referrals managed outside secondary care

48 hours

photo access for urgent cases and within 10 days for routine referrals

48 hours

ambulatory ECG analysis reports completed remotely between January and December 2025

The challenge

Routine dermatology waits at the local trust exceeded 80 weeks, creating anxiety for patients and pressure on hospital capacity. Frimley ICB wanted an alternative model that could accelerate diagnosis, reduce demand on secondary care and support GPs to manage suitable cases safely in the community.

Why Xyla

Xyla was chosen for its ability to deliver a fully consultant led service aligned with NHS pathways, supported by dermatologists who hold substantive NHS posts. This ensured high quality decision making, fast turnaround times and a smooth integration with primary care that enabled safe community-based management wherever possible.

The solution

Working closely with Frimley ICB, Xyla designed a bespoke teledermatology pathway that allowed GPs to refer patients with or without dermatoscopic images. A medical photography clinic operated up to four days per week, ensuring rapid access to high quality images for all patients. Urgent cases received images within 48 hours and routine referrals within 10 days.

Once uploaded, consultant teledermatologists remotely reviewed the images and referral information and provided a clear next step. This included referral to the acute trust when required, redirection to community dermatology clinics or a Primary Care Management Plan for the GP. The service offered consistent consultant decision making, quicker reassurance for patients and a streamlined flow of cases across primary and secondary care.

Impact

Reduced demand on secondary care

The service achieved a 40% reduction in 2 week wait referrals sent to the acute trust, helping to ease pressure on overstretched hospital services while ensuring patients with suspected cancer were escalated appropriately.

More patients treated safely in the community

40% of all referrals were managed outside secondary care, supported by high quality consultant advice and robust Primary Care Management Plans that allowed GPs to deliver timely treatment locally.

Faster reassurance and earlier intervention

Urgent photographic access within 48 hours and consultant review within the same timeframe ensured patients received rapid clarity on their symptoms. This improved the patient experience and reduced unnecessary worry.

A streamlined, clinically led pathway

The combination of flexible referrals, fast imaging and consultant input created a smoother flow of cases and delivered earlier diagnosis and treatment for conditions that previously faced long delays.

Clinician confidence and service quality

Consultant Dermatologist Rob Ellis said the model provided the optimum approach for future dermatology services, enabling early diagnosis, bespoke pathways and rapid reassurance for patients.

“Xyla teledermatology provides the optimum model for future dermatology services. Initial assessment by consultant dermatologists enables swift diagnosis and bespoke pathways. Patients with benign lesions are reassured quickly while those needing urgent care access treatment within two weeks instead of waiting months. This approach improves quality of care and fosters GP learning through immediate feedback.”

Rob Ellis, Consultant Dermatologist

Transforming access to care

Xyla helps people to avoid hospital or accelerate them safely through it. Get in touch to find out how our bespoke community solutions can support you.

Share this case study

Contact us

Have any questions about our services? Whether you’re wondering about how we can help your health goals, or assist your healthcare organisation, we’d love to hear from you.

Get in touch

Xyla is a trading name of ICS Operations Ltd (Registered No 4793945), Pulse Healthcare Limited (Registered No 3156103), Carehome Selection Limited (Registered No 3091598) & Independent Clinical Services Limited (Registered No 4768329)